Stephanie Padberg

550 total citations
28 papers, 321 citations indexed

About

Stephanie Padberg is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stephanie Padberg has authored 28 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 13 papers in Obstetrics and Gynecology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stephanie Padberg's work include Pregnancy and Medication Impact (15 papers), Pregnancy and preeclampsia studies (11 papers) and Cardiovascular Issues in Pregnancy (4 papers). Stephanie Padberg is often cited by papers focused on Pregnancy and Medication Impact (15 papers), Pregnancy and preeclampsia studies (11 papers) and Cardiovascular Issues in Pregnancy (4 papers). Stephanie Padberg collaborates with scholars based in Germany, Austria and Canada. Stephanie Padberg's co-authors include Reinhard Meister, Christof Schaefer, Christof Schaefer, P.‐M. Schumm‐Draeger, Corinna Weber‐Schoendorfer, Klaüs Heller, K. H. Usadel, Katarina Dathe, Evelin Beck and Marc Oppermann and has published in prestigious journals such as Scientific Reports, Hypertension and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Stephanie Padberg

25 papers receiving 309 citations

Peers

Countries citing papers authored by Stephanie Padberg

Since Specialization

Citations

This map shows the geographic impact of Stephanie Padberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Padberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Padberg more than expected).

Fields of papers citing papers by Stephanie Padberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Padberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Padberg. The network helps show where Stephanie Padberg may publish in the future.

Co-authorship network of co-authors of Stephanie Padberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Padberg. A scholar is included among the top collaborators of Stephanie Padberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Padberg. Stephanie Padberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study 2025 ·Clinical Microbiology and Infection ·(unknown), (unknown), Stephanie Padberg, Brigitte Keller‐Stanislawski, Doris Oberle, Evelin Beck, (unknown), Jan Beyersmann, Katarina Dathe	0
2	Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study 2024 ·Scientific Reports ·(unknown), (unknown), Stephanie Padberg, Christof Schaefer, Katarina Dathe	3
3	Risk of congenital malformations and miscarriages following maternal use of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis 2024 ·European Journal of Epidemiology ·(unknown), Catherine Vauzelle, Élisabeth Éléfant, Florence Tubach, Stephanie Padberg, Brigitte Martin, (unknown), Agnès Dechartres, Benôıt Marin	1
4	An observational study on safety of COVID-19 vaccines in pregnancy – Current status and preliminary data based on the Embryotox cohort 2023 ·Neurotoxicology and Teratology ·Stephanie Padberg, (unknown), (unknown), Katarina Dathe	1
5	Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort 2022 ·BMC Pregnancy and Childbirth ·Katarina Dathe, (unknown), Stephanie Padberg, (unknown), Evelin Beck, Christof Schaefer	14
6	First trimester naproxen exposure and outcome of pregnancy – A German case series 2021 ·Reproductive Toxicology ·(unknown), Wolfgang Paulus, Stephanie Padberg, (unknown), Christof Schaefer, Katarina Dathe	5
7	Are patients of a large paediatric nephrology department an appropriate population to investigate long-term effects of prenatal drug exposure in a retrospective approach? 2020 ·Reproductive Toxicology ·Stephanie Padberg, Julia Thumfart, (unknown), (unknown), Katarina Dathe, Christof Schaefer	0
8	Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study 2019 ·Infection ·(unknown), (unknown), (unknown), (unknown), Reinhard Meister, Christof Schaefer, Stephanie Padberg	7
9	Multistate methodology improves risk assessment under time‐varying drug intake—a new view on pregnancy outcomes following coumarin exposure 2019 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), (unknown), Evelin Beck, Stephanie Padberg, Jan Beyersmann, Christof Schaefer, Reinhard Meister	6
10	No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort 2018 ·Reproductive Toxicology ·Katarina Dathe, (unknown), (unknown), Stephanie Padberg, (unknown), (unknown), Reinhard Meister, Christof Schaefer	20
11	Safety of diclofenac use during early pregnancy: A prospective observational cohort study 2018 ·Reproductive Toxicology ·Stephanie Padberg, (unknown), Katarina Dathe, (unknown), (unknown), (unknown), Reinhard Meister, Christof Schaefer	12
12	Fremdstoffe und Krankheitserreger in der Muttermilch 2018 ·Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Stephanie Padberg, Christoph Bührer, Juliane Menzel, Cornelia Weikert, Christof Schaefer, Klaus Abraham	3
13	Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study 2017 ·European Journal of Clinical Pharmacology ·Katarina Dathe, Stephanie Padberg, (unknown), (unknown), (unknown), (unknown), (unknown), Reinhard Meister, Christof Schaefer	15
14	Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment 2017 ·Thrombosis and Haemostasis ·Stephanie Padberg, Reinhard Meister, (unknown), Evelin Beck, Christof Schaefer	15
15	Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy 2017 ·Reproductive Toxicology ·Stephanie Padberg, Inge Mick, (unknown), Richard Greil, (unknown), Christof Schaefer	11
16	Observational Cohort Study of Pregnancy Outcome after First-Trimester Exposure to Fluoroquinolones 2014 ·Antimicrobial Agents and Chemotherapy ·Stephanie Padberg, Evelin Wacker, Reinhard Meister, M. V. Panse, Corinna Weber‐Schoendorfer, Marc Oppermann, Christof Schaefer	38
17	Angiotensin‐II receptor 1 antagonist fetopathy – risk assessment, critical time period and vena cava thrombosis as a possible new feature 2012 ·British Journal of Clinical Pharmacology ·Marc Oppermann, Stephanie Padberg, (unknown), Corinna Weber‐Schoendorfer, Christof Schaefer	22
18	Paternal exposure to azathioprine/6-mercaptopurine—Experience of Berlin TIS 2010 ·Reproductive Toxicology ·Maria Hoeltzenbein, Corinna Weber‐Schoendorfer, Stephanie Padberg, (unknown), Christof Schaefer	1
19	Prophylactic levothyroxine therapy in patients with Hashimoto's thyroiditis 2009 ·Experimental and Clinical Endocrinology & Diabetes ·P.‐M. Schumm‐Draeger, Stephanie Padberg, Klaüs Heller	2
20	Wertigkeit von A1- und A2-Antikörpern gegen β-Kasein beim Typ-1-Diabetes mellitus 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Stephanie Padberg, P.‐M. Schumm‐Draeger, R. Petzoldt, (unknown), K. Federlin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact